SWK Holdings

About The Fund

SWK Holdings is a publicly traded specialized finance company catering primarily to the healthcare sector. With a reputation for innovation and flexibility, they offer bespoke capital solutions to commercial-stage healthcare and life science companies, including those involved in biopharma, medical devices, diagnostics, and life science tools. They focus on the global market, providing unique opportunities for partnership that could lead to mutual growth and success. Their approach is to preserve partners' ownership interests, while also ensuring value creation and assisting in the maximization of equity value through tailored financial strategies. They take pride in their ability to see value where others may not, offering creative capital solutions that are customized to meet the intricate needs of their partners. Their investment process involves detailed clinical data review, competitive environment review, financial modeling, market strategy review, industry expert consultation, and intellectual property review. SWK Holdings specializes in sub-$50M opportunities, signaling a capacity to work with a range of businesses from smaller ventures to more substantial enterprises. Their portfolio showcases various financing structures, from structured credit to royalty-based financings, that are designed to provide operational flexibility and support for their partners' strategic goals. SWK's commitment to their partners is evidenced by the testimonials from companies like Orametrix, Galil Medical, and Solsys Medical, who have benefited from their flexible capital solutions and business advice. Since inception, SWK and their partners have completed financings with over 55 parties, deploying around $780 million in capital. Headquartered in Dallas, Texas, SWK Holdings is positioned to be a partner for companies seeking non-dilutive capital solutions and for institutional investors looking to unlock intellectual property value.